Leishmania
Study of parasite may lead to vaccine, new treatments
Published in TB and Outbreaks Week, August 26th, 2003
The study found that parasites engineered to lack the molecule known as lipophosphoglycan (LPG) were 10 times more vulnerable to attack by an immune defense known as complement, which is found in the bloodstream. And although parasites that lack LPG easily enter macrophages (immune cells that the parasite normally infects), they were quickly destroyed once inside the cells.
The findings are published online and in the August 5, 2003, issue of the Proceedings of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Ebola Virus
Fast-acting vaccine protects monkeys - Dengue Virus
Clinical symptoms of dengue fever have limited diagnostic value - Liver Transplantation
Amphotericin B lipid complex superior to standard agent for IA treatment - Malaria Therapy
Genetically modified E. coli may enable high-yield terpenoid production - Staphylococcal Therapy
Effects of beta-lactam-vancomycin combination on hetero-VRSA depends on beta-lactam dose - Anti-Infective Medication
SBIR grants will fund lipopeptide research - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
